Leon M. Ptaszek, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 10 | 2021 | 5052 | 0.780 |
Why?
|
| Heart Conduction System | 3 | 2017 | 1001 | 0.740 |
Why?
|
| Methacrylates | 1 | 2020 | 102 | 0.700 |
Why?
|
| Tissue Adhesives | 1 | 2020 | 172 | 0.640 |
Why?
|
| Gelatin | 1 | 2020 | 219 | 0.630 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 3 | 2017 | 486 | 0.610 |
Why?
|
| Electric Countershock | 2 | 2019 | 523 | 0.610 |
Why?
|
| Software Design | 1 | 2017 | 172 | 0.580 |
Why?
|
| Ventricular Premature Complexes | 1 | 2017 | 110 | 0.550 |
Why?
|
| Critical Pathways | 2 | 2019 | 473 | 0.540 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2019 | 772 | 0.500 |
Why?
|
| Length of Stay | 3 | 2019 | 6293 | 0.490 |
Why?
|
| Marfan Syndrome | 1 | 2015 | 228 | 0.430 |
Why?
|
| Electrodes, Implanted | 2 | 2014 | 823 | 0.390 |
Why?
|
| Body Surface Potential Mapping | 1 | 2012 | 221 | 0.380 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2017 | 1487 | 0.370 |
Why?
|
| Action Potentials | 1 | 2017 | 1773 | 0.360 |
Why?
|
| Aortic Aneurysm | 1 | 2015 | 631 | 0.360 |
Why?
|
| Myocardium | 2 | 2020 | 4634 | 0.340 |
Why?
|
| Patient Admission | 1 | 2016 | 1358 | 0.320 |
Why?
|
| Patient Care Team | 1 | 2019 | 2479 | 0.310 |
Why?
|
| Anticoagulants | 2 | 2021 | 4730 | 0.300 |
Why?
|
| Regeneration | 2 | 2013 | 1491 | 0.280 |
Why?
|
| Embryonic Stem Cells | 3 | 2008 | 1265 | 0.270 |
Why?
|
| Heart Rate | 1 | 2017 | 4041 | 0.270 |
Why?
|
| Disease Management | 1 | 2016 | 2456 | 0.250 |
Why?
|
| Myocardial Infarction | 5 | 2023 | 11658 | 0.250 |
Why?
|
| Hospitalization | 4 | 2022 | 10333 | 0.250 |
Why?
|
| DNA Mismatch Repair | 1 | 2007 | 427 | 0.240 |
Why?
|
| Defibrillators, Implantable | 3 | 2015 | 1435 | 0.240 |
Why?
|
| Emergency Service, Hospital | 4 | 2021 | 7703 | 0.240 |
Why?
|
| Gene Targeting | 1 | 2007 | 838 | 0.240 |
Why?
|
| Stem Cell Transplantation | 2 | 2013 | 1597 | 0.240 |
Why?
|
| Gene Transfer Techniques | 2 | 2013 | 1202 | 0.230 |
Why?
|
| Hemochromatosis | 1 | 2005 | 170 | 0.220 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2023 | 44 | 0.220 |
Why?
|
| Genome | 2 | 2008 | 1744 | 0.210 |
Why?
|
| Atrial Appendage | 2 | 2021 | 289 | 0.200 |
Why?
|
| Image Enhancement | 1 | 2012 | 2871 | 0.200 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2023 | 121 | 0.200 |
Why?
|
| Chikungunya virus | 1 | 2021 | 52 | 0.190 |
Why?
|
| Catheter Ablation | 4 | 2018 | 2711 | 0.190 |
Why?
|
| Pacemaker, Artificial | 3 | 2019 | 807 | 0.190 |
Why?
|
| Pericardial Effusion | 2 | 2021 | 246 | 0.190 |
Why?
|
| Equipment Design | 4 | 2018 | 3510 | 0.190 |
Why?
|
| Heart Valve Prosthesis | 2 | 2022 | 1494 | 0.180 |
Why?
|
| Electrocardiography | 6 | 2019 | 6319 | 0.170 |
Why?
|
| Sus scrofa | 2 | 2018 | 426 | 0.170 |
Why?
|
| Drug Compounding | 1 | 2020 | 247 | 0.160 |
Why?
|
| Cardiomyopathies | 2 | 2015 | 1895 | 0.160 |
Why?
|
| Prosthesis Implantation | 2 | 2021 | 582 | 0.160 |
Why?
|
| Transducers, Pressure | 1 | 2018 | 51 | 0.160 |
Why?
|
| Heart | 1 | 2012 | 4359 | 0.160 |
Why?
|
| Endocarditis, Bacterial | 1 | 2022 | 444 | 0.160 |
Why?
|
| Endocarditis | 1 | 2022 | 347 | 0.150 |
Why?
|
| Hydrogels | 2 | 2020 | 718 | 0.150 |
Why?
|
| Therapeutic Irrigation | 1 | 2018 | 291 | 0.150 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 102 | 0.140 |
Why?
|
| Heart Ventricles | 3 | 2018 | 3772 | 0.140 |
Why?
|
| Prosthesis-Related Infections | 1 | 2022 | 485 | 0.140 |
Why?
|
| Troponin T | 1 | 2021 | 751 | 0.140 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2018 | 295 | 0.140 |
Why?
|
| Heart Transplantation | 2 | 2009 | 3032 | 0.130 |
Why?
|
| Lyme Disease | 1 | 2021 | 620 | 0.130 |
Why?
|
| Rest | 2 | 2017 | 908 | 0.130 |
Why?
|
| Pyridazines | 1 | 2017 | 199 | 0.130 |
Why?
|
| Tissue Engineering | 2 | 2018 | 1852 | 0.130 |
Why?
|
| Swine | 5 | 2018 | 5873 | 0.120 |
Why?
|
| Coronary Circulation | 2 | 2017 | 1558 | 0.120 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 1178 | 0.120 |
Why?
|
| Ventricular Fibrillation | 2 | 2023 | 535 | 0.110 |
Why?
|
| Equipment Failure Analysis | 2 | 2014 | 848 | 0.110 |
Why?
|
| Foreign-Body Migration | 1 | 2015 | 218 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2019 | 1218 | 0.110 |
Why?
|
| Bundle-Branch Block | 1 | 2015 | 269 | 0.110 |
Why?
|
| Homeodomain Proteins | 5 | 2011 | 2398 | 0.110 |
Why?
|
| Intraoperative Care | 1 | 2017 | 748 | 0.110 |
Why?
|
| Fibrosis | 1 | 2020 | 2012 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2021 | 12767 | 0.110 |
Why?
|
| Heart Injuries | 1 | 2014 | 205 | 0.110 |
Why?
|
| Wounds, Penetrating | 1 | 2014 | 301 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 2 | 2015 | 2038 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1897 | 0.100 |
Why?
|
| Temperature | 1 | 2018 | 2196 | 0.100 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2017 | 546 | 0.100 |
Why?
|
| Animals | 19 | 2020 | 166558 | 0.100 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 918 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 17869 | 0.090 |
Why?
|
| Cicatrix | 1 | 2017 | 769 | 0.090 |
Why?
|
| Heart Failure | 3 | 2015 | 11096 | 0.090 |
Why?
|
| Warfarin | 1 | 2019 | 1480 | 0.090 |
Why?
|
| VDJ Recombinases | 4 | 2003 | 84 | 0.090 |
Why?
|
| Lipids | 1 | 2021 | 3290 | 0.090 |
Why?
|
| Emergency Medicine | 1 | 2019 | 1186 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 19819 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1386 | 0.080 |
Why?
|
| Humans | 38 | 2023 | 746630 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2022 | 78313 | 0.080 |
Why?
|
| Recombination, Genetic | 3 | 2003 | 1532 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 1780 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 2 | 2009 | 1285 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2019 | 2730 | 0.080 |
Why?
|
| Subcutaneous Fat | 1 | 2011 | 385 | 0.080 |
Why?
|
| Cardiology | 1 | 2019 | 1676 | 0.080 |
Why?
|
| Middle Aged | 15 | 2021 | 214618 | 0.080 |
Why?
|
| Stroke | 2 | 2021 | 9693 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 20143 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 2 | 2012 | 781 | 0.070 |
Why?
|
| DNA Nucleotidyltransferases | 3 | 2002 | 176 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 3706 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2010 | 592 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1615 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2021 | 3541 | 0.070 |
Why?
|
| Pericardium | 1 | 2011 | 666 | 0.070 |
Why?
|
| Postoperative Complications | 4 | 2021 | 15356 | 0.070 |
Why?
|
| Esophageal Fistula | 1 | 2007 | 59 | 0.070 |
Why?
|
| Blastocyst | 1 | 2010 | 419 | 0.070 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 2105 | 0.070 |
Why?
|
| Angina Pectoris | 1 | 2011 | 968 | 0.070 |
Why?
|
| Male | 20 | 2021 | 351420 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2019 | 3314 | 0.070 |
Why?
|
| Aged | 11 | 2021 | 164383 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 57586 | 0.070 |
Why?
|
| Biomedical Technology | 1 | 2008 | 211 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2017 | 3073 | 0.070 |
Why?
|
| Atherosclerosis | 2 | 2020 | 3421 | 0.060 |
Why?
|
| Immunity | 1 | 2011 | 993 | 0.060 |
Why?
|
| Esophagus | 1 | 2011 | 1014 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2019 | 53253 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 15010 | 0.060 |
Why?
|
| Pulmonary Veins | 2 | 2010 | 733 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 21600 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 1 | 2011 | 991 | 0.060 |
Why?
|
| Gene Rearrangement | 2 | 2001 | 1130 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2010 | 706 | 0.060 |
Why?
|
| Time Factors | 5 | 2021 | 39622 | 0.060 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2010 | 842 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 9107 | 0.060 |
Why?
|
| Coronary Stenosis | 1 | 2011 | 814 | 0.060 |
Why?
|
| Fibroma | 1 | 2006 | 187 | 0.060 |
Why?
|
| Intracranial Embolism | 1 | 2006 | 189 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2013 | 2496 | 0.060 |
Why?
|
| Positron-Emission Tomography | 2 | 2018 | 6419 | 0.060 |
Why?
|
| Models, Molecular | 1 | 1994 | 5379 | 0.060 |
Why?
|
| DNA | 6 | 2010 | 7208 | 0.060 |
Why?
|
| CpG Islands | 1 | 2008 | 1199 | 0.060 |
Why?
|
| Adult | 10 | 2021 | 215192 | 0.060 |
Why?
|
| Echocardiography, Stress | 1 | 2005 | 134 | 0.060 |
Why?
|
| Heart Atria | 1 | 2010 | 1321 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 35797 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 1611 | 0.050 |
Why?
|
| Female | 15 | 2021 | 382450 | 0.050 |
Why?
|
| Prosthesis Failure | 2 | 2021 | 1204 | 0.050 |
Why?
|
| Age Factors | 2 | 2021 | 18157 | 0.050 |
Why?
|
| Recurrence | 1 | 2015 | 8384 | 0.050 |
Why?
|
| Heart Neoplasms | 1 | 2006 | 359 | 0.050 |
Why?
|
| Liver Failure | 1 | 2005 | 248 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5096 | 0.050 |
Why?
|
| Massachusetts | 1 | 2015 | 8609 | 0.050 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2005 | 545 | 0.050 |
Why?
|
| California | 1 | 2005 | 1389 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 1699 | 0.050 |
Why?
|
| Electronics | 1 | 2022 | 319 | 0.050 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2009 | 1529 | 0.050 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2021 | 117 | 0.050 |
Why?
|
| Stem Cells | 1 | 2013 | 3513 | 0.040 |
Why?
|
| Wound Healing | 1 | 2011 | 2750 | 0.040 |
Why?
|
| Cardiac Tamponade | 1 | 2021 | 169 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 14543 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1825 | 0.040 |
Why?
|
| Burns | 1 | 2011 | 1846 | 0.040 |
Why?
|
| Device Approval | 1 | 2021 | 162 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2006 | 939 | 0.040 |
Why?
|
| Sotalol | 1 | 2019 | 46 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2011 | 4513 | 0.040 |
Why?
|
| Steam | 1 | 2018 | 32 | 0.040 |
Why?
|
| High Mobility Group Proteins | 1 | 1999 | 172 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2021 | 570 | 0.040 |
Why?
|
| Ink | 1 | 2018 | 41 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2013 | 10138 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2014 | 23464 | 0.040 |
Why?
|
| Drug Implants | 1 | 2018 | 230 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7572 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2008 | 2964 | 0.040 |
Why?
|
| Risk Factors | 5 | 2015 | 72447 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2000 | 575 | 0.040 |
Why?
|
| Placebos | 1 | 2021 | 1659 | 0.040 |
Why?
|
| Binding Sites | 4 | 2002 | 6030 | 0.040 |
Why?
|
| Chromatin | 1 | 2008 | 2896 | 0.040 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2000 | 551 | 0.030 |
Why?
|
| DNA-Binding Proteins | 4 | 2002 | 9525 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 11966 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2009 | 2764 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 676 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2006 | 1972 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2017 | 63732 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 782 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9320 | 0.030 |
Why?
|
| Genome, Human | 1 | 2008 | 4358 | 0.030 |
Why?
|
| Hemothorax | 1 | 2015 | 57 | 0.030 |
Why?
|
| Platelet-Rich Plasma | 1 | 2018 | 177 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 3654 | 0.030 |
Why?
|
| Hypotension | 1 | 2021 | 865 | 0.030 |
Why?
|
| Materials Testing | 1 | 2018 | 852 | 0.030 |
Why?
|
| Incidence | 3 | 2021 | 20820 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10311 | 0.030 |
Why?
|
| Chemistry, Physical | 1 | 1994 | 154 | 0.030 |
Why?
|
| Chemical Phenomena | 1 | 1994 | 508 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 1271 | 0.030 |
Why?
|
| Alcoholism | 1 | 2005 | 1922 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2020 | 1483 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2014 | 259 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2020 | 18905 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2017 | 683 | 0.030 |
Why?
|
| Mice | 9 | 2020 | 80251 | 0.030 |
Why?
|
| Thermodynamics | 1 | 1994 | 593 | 0.030 |
Why?
|
| Prognosis | 3 | 2021 | 29079 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2005 | 5142 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 2116 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 12840 | 0.020 |
Why?
|
| Inpatients | 1 | 2023 | 2515 | 0.020 |
Why?
|
| Luciferases | 1 | 2013 | 716 | 0.020 |
Why?
|
| Kinetics | 2 | 2013 | 6361 | 0.020 |
Why?
|
| Transposases | 2 | 2002 | 102 | 0.020 |
Why?
|
| Hospital Mortality | 2 | 2015 | 5217 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 535 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1650 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1654 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9213 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2021 | 1916 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2854 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2011 | 391 | 0.020 |
Why?
|
| Protein Conformation | 3 | 2002 | 3959 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 38771 | 0.020 |
Why?
|
| Base Sequence | 3 | 2010 | 12456 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2011 | 523 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 2225 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1232 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2010 | 1060 | 0.020 |
Why?
|
| Dimerization | 2 | 2001 | 886 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3789 | 0.020 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2008 | 111 | 0.020 |
Why?
|
| Chest Pain | 1 | 2015 | 1095 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2011 | 1018 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2019 | 2683 | 0.020 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2008 | 169 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 4180 | 0.020 |
Why?
|
| Dyspnea | 1 | 2015 | 1308 | 0.020 |
Why?
|
| Chemokines | 1 | 2011 | 963 | 0.020 |
Why?
|
| Substrate Specificity | 2 | 2002 | 1782 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2010 | 17689 | 0.020 |
Why?
|
| Thrombosis | 1 | 2021 | 2998 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 2002 | 6517 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2019 | 2867 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 749 | 0.020 |
Why?
|
| Syncope | 1 | 2009 | 422 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 3962 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 5166 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 1719 | 0.020 |
Why?
|
| Methylation | 1 | 2008 | 1076 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 866 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7815 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 2411 | 0.020 |
Why?
|
| Logistic Models | 2 | 2011 | 13170 | 0.020 |
Why?
|
| Models, Biological | 2 | 2013 | 9455 | 0.020 |
Why?
|
| Adipocytes | 1 | 2011 | 1168 | 0.020 |
Why?
|
| Point Mutation | 1 | 2010 | 1600 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2011 | 2671 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3429 | 0.010 |
Why?
|
| Cattle | 1 | 2010 | 3840 | 0.010 |
Why?
|
| Computational Biology | 2 | 2008 | 3489 | 0.010 |
Why?
|
| Triage | 1 | 2011 | 959 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6460 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2013 | 11384 | 0.010 |
Why?
|
| DNA, Intergenic | 1 | 2003 | 104 | 0.010 |
Why?
|
| Genes, RAG-1 | 1 | 2002 | 67 | 0.010 |
Why?
|
| Transfection | 2 | 2002 | 5789 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 2003 | 278 | 0.010 |
Why?
|
| Cell Line | 3 | 2003 | 15642 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 2002 | 346 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2011 | 4118 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 3473 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 9599 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 6068 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 2019 | 4687 | 0.010 |
Why?
|
| Survival Rate | 1 | 2015 | 12645 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2002 | 772 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 4622 | 0.010 |
Why?
|
| Trypsin | 1 | 2001 | 493 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2013 | 3486 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 57163 | 0.010 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2000 | 93 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2003 | 580 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4617 | 0.010 |
Why?
|
| Acute Disease | 1 | 2011 | 7124 | 0.010 |
Why?
|
| Titrimetry | 1 | 1999 | 35 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2003 | 1225 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2009 | 1483 | 0.010 |
Why?
|
| Escherichia coli | 2 | 2002 | 4168 | 0.010 |
Why?
|
| Mutation | 2 | 2000 | 29627 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 4868 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 2275 | 0.010 |
Why?
|
| Histones | 1 | 2008 | 2552 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2000 | 13503 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2009 | 2057 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1999 | 1139 | 0.010 |
Why?
|
| Catalysis | 1 | 1999 | 764 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2000 | 692 | 0.010 |
Why?
|
| Apoptosis | 1 | 2013 | 9447 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12021 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 5761 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2000 | 1174 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12227 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 1689 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2003 | 2589 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 1744 | 0.010 |
Why?
|
| Zinc | 1 | 1999 | 682 | 0.010 |
Why?
|
| United States | 2 | 2014 | 70437 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 3425 | 0.010 |
Why?
|
| Registries | 1 | 2009 | 8173 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2898 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 9284 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 3724 | 0.010 |
Why?
|
| Software | 1 | 2003 | 4400 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2003 | 5031 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 40534 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 10018 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 5748 | 0.000 |
Why?
|
| Algorithms | 1 | 2003 | 13810 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 35456 | 0.000 |
Why?
|